Somatostatin receptor scintigraphy: Its value in tumor localization in patients with cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion

https://doi.org/10.1016/0002-9343(94)90059-0Get rights and content

Abstract

purpose: To assess the feasibility of somatostatin receptor scintigraphy for patients with Cushing's syndrome caused by tumors secreting ectopic corticotropin or corticotropin-releasing hormone (CRH).

patients and methods: Ten patients with Cushing's syndrome, nine with ectopic corticotropin-secreting tumors and one with a CRH-secreting tumor, were consecutively studied. For comparison purposes, eight patients with corticotropin-secreting pituitary tumors and one patient with an autonomous adrenal adenoma were investigated. In vivo tumor localization was performed for all patients using a radionuclide-coupled somatostatin analog. The results obtained with this technique were compared with those obtained with conventional imaging techniques. For some patients, the clinical effects of octreotide therapy were evaluated.

results: Somatostatin analog scintigraphy successfully identified the primary ectopic corticotropin-secreting and CRH-secreting tumors or their metastases, or both, in 8 of 10 patients; in 2 patients with corticotropin-secreting bronchial carcinoids, the tumors could not be visualized. Normal scans were obtained for the 8 patients with corticotropin-secreting pituitary tumors and the one patient with an adrenal adenoma.

conclusion: Somatostatin analog scintigraphy can be included as a diagnostic step in the workup of Cushing's syndrome patients with a suspected ectopic corticotropin-secreting tumor or a CRH-secreting tumor.

References (37)

  • SWJ Lamberts et al.

    The effect of the long-acting somatostatin analogue SMS 201-995 on ACTH secretion in Nelson's syndrome and Cushing's disease

    Acta Endocrinol (Copenh)

    (1989)
  • SWJ Lamberts et al.

    Somatostatin-receptor imaging in the localization of endocrine tumors

    NEJM

    (1990)
  • SWJ Lamberts et al.

    The role of somatostatin and its analogs in the treatment of tumors

    Endocr Rev

    (1991)
  • WH Bakker et al.

    Receptor scintigraphy with a radioiodinated somatostatin analogue: radiolabeling, purification, biological activity, and in vivo application in animals

    J Nucl Med

    (1990)
  • EP Krenning et al.

    Somatostatin receptor scintigraphy with [In-111DTPA-D-Phe1]-octreotide in man: metabolism, dosimetry and comparison with [123I-Tyr3]-octreotide

    J Nucl Med.

    (1992)
  • SWJ Lamberts et al.

    Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy

    J Clin Endocrinol Metab.

    (1990)
  • JW Findling et al.

    Routine inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin (ACTH)-dependent Cushing's syndrome: early recognition of the occult ectopic ACTH syndrome

    J Clin Endocrinol Metab.

    (1991)
  • PK Bondy et al.

    Endocrine function in small cell undifferentiated lung cancer

    Cancer

    (1981)

    • Cited by (0)

    View full text
    Copyright © 1994 Published by Excerpta Medica Inc.